CSIMarket Company Name, Ticker, Suppliers, else..
 
• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Intuitive Surgical Inc   (ISRG)
Other Ticker:  
 

Intuitive Surgical Inc 's Working Capital Per Sales

ISRG's Working Capital and Revenue growth



ISRG Working Capital Per Revenue (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Working Capital Change -5.03 % 12.35 % 28.95 % 42.82 % 26.89 %
Y / Y Revenue Change 14.45 % 11.45 % 16.51 % 11.93 % 15.36 %
Working Capital Per Revenue 0.85 0.9 0.9 0.88 0.82
Total Ranking # 88 # 2135 # 174 # 1956 # 390
Seq. Working Capital Change -1.45 % 0.45 % -13.8 % 11.29 % 16.59 %
Seq. Revenue Change 6.31 % -1.96 % 10.61 % -0.72 % 3.52 %


New: More ISRG's historic Working Capital Per Revenue Ratios >>


See ISRG Capital expenditures by quarter >> Back to ISRG Financial Strength Comparisons >> See ISRG Balance Sheets

Comment on ISRG's Working Capital Per Revenue in the second quarter 2024
Intuitive Surgical Inc 's Working Capital Per Revenue in the Q2 2024 sequentially fell to 0.85 but remained above Intuitive Surgical Inc 's average.

Within Healthcare sector only one company has achieved lower Working Capital Per Revenue. While Intuitive Surgical Inc Working Capital Per Revenue overall ranking has impoved so far in the Q2 2024 to 88, from total ranking in the first quarter 2024 at 2135.
Working Capital Per Revenue Ranking
Within: No.
Industry # 0
Sector # 2
S&P 500 # 88


Working Capital Per Revenue Statistics
High Average Low
1.16
0.72
0.37
(Mar 31 2021)   (Dec 31 2013)



Financial Statements
Intuitive Surgical Inc 's Working Capital $ 6,167 Millions Visit ISRG's Balance sheet
Intuitive Surgical Inc 's Revenues $ 2,010 Millions Visit ISRG's Income Statement
Where are ISRG's Sales coming from? Visit ISRG's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Jun 30 2024, within Healthcare Sector Working Capital Per Revenue
Zai Lab Limited  2.24 
Nutriband Inc   2.21 
Cvrx inc   2.19 
Theravance Biopharma inc   2.16 
Ligand Pharmaceuticals Incorporated  2.14 
Cryoport inc   2.12 
Veru Inc   2.12 
Urogen Pharma Ltd   2.11 
Vanda Pharmaceuticals Inc   2.04 
Schrodinger Inc   2.04 
Zevra Therapeutics Inc   2.00 
  1.99 
Voyager Therapeutics Inc   1.97 
Delcath Systems Inc   1.94 
Dariohealth Corp   1.94 
  1.89 
Hookipa Pharma inc   1.85 
Insmed Inc  1.79 
Cytek Biosciences Inc   1.73 
Guardant Health Inc   1.72 
Procept Biorobotics Corporation  1.72 
Pulmonx Corporation  1.71 
Blueprint Medicines Corporation  1.65 
Aurinia Pharmaceuticals Inc   1.64 
  1.60 
Novocure Limited  1.60 
Jaguar Health Inc   1.48 
Bionano Genomics Inc   1.48 
The Beauty Health Company  1.46 
Biomerica Inc   1.42 
Date modified: 2024-09-08T14:28:39+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com